Open original FDA record ↗Recall record
- FDA identifier
- Z-0894-2022
- Company in FDA record
- Ventana Medical Systems Inc
- FDA classification date
- Apr 8, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for Fluid Leak inside a staining system that could cause an electrical short circuit of the General Purpose Input/ Output Board's J1 Connector that could result in smoke and fire.
Source facts
- Action
- On 01/20/22, correction notices were sent to customers who were asked to take the following actions needed to continue affected device use: 1) Inform any operators of the potential hazards associated with this issue and provide a copy of this notification as appropriate. 2) Inspect the instrument daily for evidence of leaks (i.e., liquid on the floor, or in and around the instrument). 3) If you experience a fluid leak, stop using the system and turn off the power to the instrument. Immediately contact the firm's Network Customer Support Center at 1-800-227-2155. 4) Complete the attached fax back form and return via fax or email. 5) If your facility has distributed the affected product to another site, please ensure this UMDC is provided to that site. 6) File this UMDC for future reference. The firm will send a representative to schedule a visit to perform an inspection, reroute cables, and replace parts as necessary to help mitigate the issue. Customers with questions were encouraged to call the Customer Support Center at the before mentioned number; support is available 24 hours a day, seven days a week. On 4/19/23, correction notices were distributed to additional customers who may have received devices without a drip loop, which is the solution to this event. Customers were told they would be contacted by a Service Representative to coordinate specific service actions, including the inspection of GPIO boards and rerouting cables - drip loop introduction.
- Initiated
- 2022-01-20
- Root cause
- Device Design
- Distribution
- US: CA, IL, PA, FL, AZ, NY, OH, CO, AR, NC, MD, AL, AK, LA, IA, MN, MA, ND, IN, TX, TN, CT, SC, GA, UT, WI, VA, SD, KY, MS, MO, DE, MI, MT, NJ, WV, OK, WA, OR, PR, DC, NM, ID, NH, NE, ME, KS, HI, NV, RI, WY, VT OUS: Australia, Austria, Belgium, Canada, China, Croatia, Denmark, Finland, France, Germany, Hong Kong, Hungary, India, Israel, Italy, Japan, Netherlands, Norway, Poland, Portugal, Russian Fed., Singapore, South Korea, Spain, Sweden, Switzerland, United Kingdom, Algeria, Argentina, Aruba, Bosnia-Herzegovina., Brazil, Bulgaria, Chile, Colombia, Costa Rica, Cuba, Cyprus, Czech Republic, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Greece, Indonesia, Ireland, Kazakhstan, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Macedonia, Malaysia, Martinique, Mexico, Monaco, Morocco, Namibia, New Zealand, Oman, Pakistan, Panama, Peru, Philippines, Reunion, Romania, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Taiwan, Thailand, Turkey, Ukraine, United Arab Emirates, Vietnam, White Russia, Zimbabwe
- Recall number
- Z-0894-2022
- Recall status
- Open, Classified
- CDRH record ID
- 192315
- FDA classified
- 2022-04-08
- Recall event number
- 89727